Lv3
342 积分 2023-10-17 加入
Quizartinib plus chemotherapy in newly diagnosed patients with FLT3-internal-tandem-duplication-positive acute myeloid leukaemia (QuANTUM-First): a randomised, double-blind, placebo-controlled, phase 3 trial
15小时前
已完结
Gene Mutations and Targeted Therapies of Myeloid Sarcoma
1个月前
已完结
Frontline therapy of acute myeloid leukemia with lower intensity regimens: Where are we now and where can we go?
2个月前
已完结
Venetoclax plus cytarabine and azacitidine in relapsed/refractory AML: An open-label, single-arm, phase 2 study
2个月前
已关闭
A phase 2 study of chidamide in combination with CAG and venetoclax-azacitidine in acute myeloid leukemia: Clinical safety, efficacy, and correlative analysis
2个月前
已完结
Homoharringtonine sensitized resistant acute myeloid leukemia cells to venetoclax-induced apoptosis
2个月前
已完结
Homoharringtonine Added to Venetoclax and Azacitidine Improves Outcome and Mitigates Genetic Impact in Relapsed/Refractory AML: A Multicenter Cohort Study
2个月前
已完结
Intracranial myeloid sarcoma
2个月前
已完结
Gastrointestinal Myeloid Sarcoma
2个月前
已完结
骨改良药物安全性管理专家共识
3个月前
已完结
皖公网安备34019202002308
